Breaking News on Global Pharmaceutical Technology & Manufacturing

GE unveils hardware/media marriage for purification

06-May-2004

Related topics: Processing equipment, Processing

GE Healthcare has launched a large-scale separation system for use in the manufacture of peptide and protein drugs, which should reduce the cost and improve the purification of biopharmaceuticals.

The company, recently formed by combination of the former Amersham and GE Medical Systems, noted that the system combines the high-performance liquid chromatography (HPLC) hardware expertise of GE, marketed under the BioProcess brand, with the Kromasil media developed by Akzo Nobel subsidiary Eka Chemicals.

This combination of columns and media is claimed to optimise the purification of biopharmaceuticals, synthetic peptides, synthetic oligonucleotides and small organic molecules which will "lead to verified and documented procedures to meet the exacting performance demands of reversed phase chromatography (RPC) applications,"according to the GE.

 

A spokesman for the company said that cost-savings would come from a number of areas, including improvements in column packing.

 

"By combining GE Healthcare's strength in HPLC column technology with those of Kromasil in RPC media, customers purifying peptides and proteins at large scale will have access to a complete solution," commented Mats Grahn, vice president of protein separations product management at the company .

 

Copyright - Unless otherwise stated all contents of this web site are © 2012 - William Reed Business Media SAS - All Rights Reserved - For permission to reproduce any contents of this web site, please email our Syndication department copyright@wrbm.com - Full details for the use of materials on this site can be found in the Terms & Conditions

© 2012 - William Reed Business Media SAS - All rights reserved.